What is AMGN's current stock price?

As of now, AMGN is trading at $338.36, with a daily change of +0.26%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

AMGN Stock Analysis & IQ Rating | Amgen

AMGN

Amgen

$338.36

+$0.87 | +0.26%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$345.78

MKT CAP

$182.20B

52W Low

$253.3

VOL

$2.28M

P/E Ratio

48.31

AVG VOL

$2.67M

RSI

62.13

TREND

Uptrend

AMGN Stock IQ

Login to see Amgen (AMGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

AMGN Target Price

Login to display

Strengths

AMGN Rewards

Earnings are forecast to grow

AMGN Rewards

Trading below its fair value

AMGN Rewards

Upgraded on attractively valued

Technical Indicators

AMGN Technical Indicators

Overbought

AMGN Price Performance

$298.43 (+13.38%)

$280.1 (+20.80%)

$296.52 (+14.11%)

$273.41 (+23.76%)

1year

6month

3month

1month

AMGN Risk Level

AMGN has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

AMGN Analysts Opinion

AMGN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

AMGN Analysts Opinion

AMGN Analysts opinion is positive but there was a setback from the past 3 months

AMGN Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

75%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

67%

75%

AMGN Street Sentiment

AMGN Street Sentiment is bullish and have positive views on the near-term outlook

AMGN Performance Sentiment

Sentiments overview associated with AMGN events and the stock performance.

75%

21%

Positive

Negative

21 out of 28
events present

6 out of 28
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$344.57

Resistance
Price

$292.00

Current Price Range

$344.57

Show methods +

Linked to AMGN

IQ

Close Price

Change

MRNA

3.62

24.06

-0.41%

BIIB

4.24

180.18

+1.35%

EXEL

4.27

43.44

+0.02%

CRSP

3.92

51.58

-1.13%

CHRS

2.35

1.16

-8.66%

AMGN Latest Analysis +

Noteworthy Monday Option Activity: AMGN NLY CRM. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Amgen Inc (Symbol: AMGN) where a total of 16674 contracts have traded so far representing approximately 1.7 million underlying shares. That amounts to about 54.6% of

Mon Dec 1, 2025

$337.49 | -2.31%

Momentum

AMGN Up Almost 16% in a Month: Should You Buy Sell or Hold the Stock?. Amgens nearly 16% surge follows strong Q3 results raised sales guidance and growing momentum across key drugs and biosimilars.

Mon Dec 1, 2025

$337.49 | -2.31%

Earnings

Potential

ARWR: Multiple Data Readouts Ahead in 2026. By Business UpdateMultiple Data Readouts Ahead in 2026Following the recent approval of REDEMPLO® for the treatment of patients with familial chylomicronemia syndrome (FCS) Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) is now a commercial-stage company and recently reported that the drug is available for patients only one week following approval which is ahead of schedule. While the company is focused on a successful commercial launch there are a number

Mon Dec 1, 2025

$337.49 | -2.31%

Activity

AMGEN TO PRESENT AT CITIS 2025 GLOBAL HEALTHCARE CONFERENCE. THOUSAND OAKS Calif. Nov. 24 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citis 2025 Global Healthcare Conference at 1:45 p.m. ET on December 3 2025. Peter Griffith executive vice president and chief financial officer at Amgen and Jay Bradner executive vice president...

Mon Nov 24, 2025

$334.30 | -0.96%

Activity

Heres Why Amgen (AMGN) is a Strong Momentum Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Mon Nov 24, 2025

$334.30 | -0.96%

Momentum

Amgens IMDELLTRA Gets Full FDA Approval For Extensive Stage Small Cell Lung Cancer . (RTTNews) - Amgen (AMGN) announced that the United States Food and Drug Administration has granted full approval to IMDELLTRA (tarlatamab-dlle) for the treatment of adult patients with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based che

Thu Nov 20, 2025

$336.07 | -1.85%

Activity

FDA Grants Full Approval To Amgens Lung Cancer Drug IMDELLTRA . (RTTNews) - Amgen Inc. (AMGN) announced that the United States FDA has granted full approval to IMDELLTRA for adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.

Thu Nov 20, 2025

$336.07 | -1.85%

Activity

Ex-Dividend Reminder: NextEra Energy Amgen and CRH . Looking at the universe of stocks we cover at Dividend Channel on 11/21/25 NextEra Energy Inc (Symbol: NEE) Amgen Inc (Symbol: AMGN) and CRH plc (Symbol: CRH) will all trade ex-dividend for their respective upcoming dividends. NextEra Energy Inc will pay its quarterly divide

Wed Nov 19, 2025

$342.40 | -0.46%

Activity

Dow Movers: NKE AMGN. In early trading on Monday shares of Amgen topped the list of the days best performing Dow Jones Industrial Average components trading up 1.2%. Year to date Amgen registers a 30.8% gain.And the worst performing Dow component thus far on the day is Nike trading down 1.6%

Mon Nov 17, 2025

$341.71 | +1.48%

Momentum

Piper Sandler Maintains Amgen (AMGN) Overweight Recommendation. Fintel reports that on November 14 2025 Piper Sandler maintained coverage of Amgen (NasdaqGS:AMGN) with a Overweight recommendation. Analyst Price Forecast Suggests 4.87% Downside

Fri Nov 14, 2025

$336.74 | +0.32%

Momentum

Rating

FAQ About AMGN Stock Insights

What is AMGN current stock price?

What are AMGN stock strengths?

What is AMGN Risk Level?

What is AMGN market cap and volume?

What is AMGN current Stock IQ?

Should I buy AMGN stock right now?

Is AMGN a Strong Buy right now?

What does a 'Strong Buy' rating mean for AMGN?

What does a 'Strong Sell' rating mean for AMGN?

What factors influence AMGN's Stock IQ?

Explore our AMGN Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored AMGN Stock Strategies
Effective Risk Management

FIND US ON

Receive our AMGN Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

AMGN

Amgen

Current Price

$338.36

+$0.87 | +0.26%

52W High

$345.78

MKT CAP

$182.20B

52W Low

$253.3

VOL

$2.28M

P/E Ratio

48.31

AVG VOL

$2.67M

RSI

62.13

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

AMGN Rewards

Earnings are forecast to grow

AMGN Rewards

Trading below its fair value

AMGN Rewards

Upgraded on attractively valued

Technical Indicators

AMGN Technical Indicators

Overbought

Linked to AMGN

Symbol

IQ

Close

Change

MRNA

3.62

24.06

-0.41%

BIIB

4.24

180.18

+1.35%

EXEL

4.27

43.44

+0.02%

CRSP

3.92

51.58

-1.13%

CHRS

2.35

1.16

-8.66%

AMGN Price Performance

$298.43 (+13.38%)

$280.1 (+20.80%)

$296.52 (+14.11%)

$273.41 (+23.76%)

1year

6month

3month

1month

AMGN Analysts Opinion

AMGN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

AMGN Analysts Opinion

AMGN Analysts opinion is positive but there was a setback from the past 3 months

AMGN Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

75%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

67%

75%

AMGN Street Sentiment

AMGN Street Sentiment is bullish and have positive views on the near-term outlook

AMGN Risk Level

AMGN has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

AMGN Performance Sentiment

Sentiments overview associated with AMGN events and the stock performance.

75%

21%

Positive

Negative

21 out of 28
events present

6 out of 28
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$344.57

Resistance
Price

$292.00

Current Price Range

$344.57

Show methods +

AMGN Stock IQ

Login to unlock Amgen (AMGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

AMGN Latest Analysis

Noteworthy Monday Option Activity: AMGN NLY CRM. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Amgen Inc (Symbol: AMGN) where a total of 16674 contracts have traded so far representing approximately 1.7 million underlying shares. That amounts to about 54.6% of

Mon Dec 1, 2025

$337.49 | -2.31%

Momentum

AMGN Up Almost 16% in a Month: Should You Buy Sell or Hold the Stock?. Amgens nearly 16% surge follows strong Q3 results raised sales guidance and growing momentum across key drugs and biosimilars.

Mon Dec 1, 2025

$337.49 | -2.31%

Earnings

Potential

ARWR: Multiple Data Readouts Ahead in 2026. By Business UpdateMultiple Data Readouts Ahead in 2026Following the recent approval of REDEMPLO® for the treatment of patients with familial chylomicronemia syndrome (FCS) Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) is now a commercial-stage company and recently reported that the drug is available for patients only one week following approval which is ahead of schedule. While the company is focused on a successful commercial launch there are a number

Mon Dec 1, 2025

$337.49 | -2.31%

Activity

AMGEN TO PRESENT AT CITIS 2025 GLOBAL HEALTHCARE CONFERENCE. THOUSAND OAKS Calif. Nov. 24 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citis 2025 Global Healthcare Conference at 1:45 p.m. ET on December 3 2025. Peter Griffith executive vice president and chief financial officer at Amgen and Jay Bradner executive vice president...

Mon Nov 24, 2025

$334.30 | -0.96%

Activity

Heres Why Amgen (AMGN) is a Strong Momentum Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Mon Nov 24, 2025

$334.30 | -0.96%

Momentum

Amgens IMDELLTRA Gets Full FDA Approval For Extensive Stage Small Cell Lung Cancer . (RTTNews) - Amgen (AMGN) announced that the United States Food and Drug Administration has granted full approval to IMDELLTRA (tarlatamab-dlle) for the treatment of adult patients with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based che

Thu Nov 20, 2025

$336.07 | -1.85%

Activity

FDA Grants Full Approval To Amgens Lung Cancer Drug IMDELLTRA . (RTTNews) - Amgen Inc. (AMGN) announced that the United States FDA has granted full approval to IMDELLTRA for adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.

Thu Nov 20, 2025

$336.07 | -1.85%

Activity

Ex-Dividend Reminder: NextEra Energy Amgen and CRH . Looking at the universe of stocks we cover at Dividend Channel on 11/21/25 NextEra Energy Inc (Symbol: NEE) Amgen Inc (Symbol: AMGN) and CRH plc (Symbol: CRH) will all trade ex-dividend for their respective upcoming dividends. NextEra Energy Inc will pay its quarterly divide

Wed Nov 19, 2025

$342.40 | -0.46%

Activity

Dow Movers: NKE AMGN. In early trading on Monday shares of Amgen topped the list of the days best performing Dow Jones Industrial Average components trading up 1.2%. Year to date Amgen registers a 30.8% gain.And the worst performing Dow component thus far on the day is Nike trading down 1.6%

Mon Nov 17, 2025

$341.71 | +1.48%

Momentum

Piper Sandler Maintains Amgen (AMGN) Overweight Recommendation. Fintel reports that on November 14 2025 Piper Sandler maintained coverage of Amgen (NasdaqGS:AMGN) with a Overweight recommendation. Analyst Price Forecast Suggests 4.87% Downside

Fri Nov 14, 2025

$336.74 | +0.32%

Momentum

Rating

Discover AMGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AMGN. We're here to help you make informed investment decisions today.

FIND US ON

Receive our AMGN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AMGN Stock trends

AMGN Stock performance

AMGN Stock analysis

AMGN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AMGN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AMGN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

AMGN Stock Analysis & IQ Rating | Amgen

AMGN Stock IQ

AMGN Target Price

AMGN Risk Level

AMGN Analysts Opinion

AMGN Street Sentiment

AMGN Performance Sentiment

Technical Price Levels

Explore our AMGN Stock insights

Receive our AMGN Daily Alerts

AMGN Street Sentiment

AMGN Risk Level

Technical Price Levels

Discover AMGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AMGN. We're here to help you make informed investment decisions today.

Receive our AMGN Daily Alerts

AMGN Runner Alarm